InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Chin Peter Scott. Director active across 1 company, notably Denali Therapeutics Inc.. In total, 1 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €32k. Activity tracked since 4 September 2026. The latest transaction was disclosed on 4 September 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration